This Tuesday (18), the Instituto Neymar Jr. received a visit from Dr. Gregory Markarian, CEO of Alignmed Brasil, a technology company operating in the sports and health market. A partner of INJR since December 2021, Alignmed is present in the routine of the young people served because it believes in the social work carried out by the project.
Foto: Instituto Neymar Jr.
Taking advantage of his time in Brazil, Dr. Gregory Markarian, visited the institution for the third time. The CEO participated in sports and educational classes, spoke with children and employees to convey messages encouraging education, sports and promoting health and well-being.
For Dr., the Neymar Jr. It is a serious project that is transforming lives. “I’m super impressed with you guys, congratulations! You come to Instituto Neymar to learn, you have many opportunities here and, because of this opportunity, there are no limits for you. Make your dreams come true, because they have no limit. With ethics, family values and humility you will find success”, he says.
Foto: Instituto Neymar Jr.
According to the Administrative Director of the INJR, José Benício da Silva Santos, receiving partners who share the same values as the Institute is always synonymous with gratitude. “The purposes that we always propagate, when they are absorbed by the partners who arrive here and visit and understand this whole process, first of creation, then of execution, we are very happy”, he says.
Foto: Instituto Neymar Jr.
ABOUT ALIGNMED
Alignmed Brasil is a technology and lifestyle company designed, researched and developed with a renowned group of doctors and sports scientists. The company uses science and technology for exoskeletal garments with an anatomical matrix of bands, panels and seams, collectively called NeuroBands®.
NeuroBands technology can be used to retrain inappropriate postures due to habitual movement behaviors caused by prolonged and repetitive motion sessions such as cell phone, computer, electronics or sports injury. The technology is supported by unprecedented research of clinical experience in more than 200,000 people to date who have used the products.
